Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-02

Clinical Trial Update: Treatment of Asymptomatic Toxocariasis With Albendazole in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating albendazole for asymptomatic toxocariasis in children is underway, with the current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)

Snippet

Sponsor: Hospital de Niños R. Gutierrez de Buenos Aires | Conditions: Toxocariasis | Phase 3 | Status: UNKNOWN